514 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Boston Scientific recalled 3,620 VALITUDE CRT-P pacemakers on August 20, 2025, due to a software flaw. The issue may prevent the device from operating correctly in ambulatory settings. Patients and healthcare providers must stop using the device immediately.
Boston Scientific recalled 190,088 ESSENTIO DR EL MRI Pacemakers on August 20, 2025. A software issue may prevent proper device operation in ambulatory settings. Patients must stop using the device immediately and follow recall instructions.
Boston Scientific recalled 32,695 pacemakers on August 20, 2025. The recall affects multiple models due to software that may prevent initiation of Safety Mode. This defect poses a high hazard level to patients who rely on these devices.
Boston Scientific recalled 61,700 ESSENTIO SR SL MRI Pacemakers on August 20, 2025, due to a software issue. The software failure can lead to the device entering Safety Mode unexpectedly in high battery impedance situations. Patients must stop using the device immediately and follow recall instructions from their healthcare provider.
Medline Industries recalled 2,680 bottles of Povidone-Iodine 10% Solution on August 19, 2025. The product is subpotent, posing a risk to users. Consumers should stop use immediately and contact their healthcare provider.
Lannett Company recalled 4,848 bottles of Dextroamphetamine tablets on August 19, 2025. The recall stems from the presence of a foreign tablet in some bottles. This poses a significant risk to consumers who may inadvertently take the incorrect dosage.
Amneal Pharmaceuticals recalled 7,228 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall occurred due to the presence of a micro-organism in the packaging material. No micro-organisms were found on the tablets themselves.
Boston Scientific recalled one unit of the Preventive Maintenance Kit ICEFX on August 18, 2025. Certain desiccant tube subassemblies had improperly tightened end caps. This recall affects distribution in the US, Canada, France, Germany, and Italy.
Amneal Pharmaceuticals recalled over 133,000 bottles of Sulfamethoxazole and Trimethoprim Tablets on August 18, 2025. The recall stems from the detection of a microorganism in the packaging material, raising health concerns. No microorganisms were found on the tablets themselves.
B. Braun Medical, Inc. recalled 46,032 containers of Lactated Ringer's Injection on August 18, 2025. The recall follows reports of particulate matter found in the solution. This Class I recall affects products distributed nationwide in the U.S.
Amneal Pharmaceuticals recalled 13,130 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025, due to contamination concerns. The recall affects specific lots identified by their lot numbers AM240147, AM240148, AM240664, and AM240665. Consumers should stop using the tablets immediately and contact their healthcare provider for further guidance.
Amneal Pharmaceuticals recalled 3,363 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. The recall stems from the presence of a microorganism in packaging material. No microorganisms were detected in the tablets themselves, but consumers should stop using the product immediately.
Amneal Pharmaceuticals recalled 14,923 bottles of Chlorpromazine Hydrochloride Tablets on August 18, 2025. A specific lot of polyester coil used in product packaging tested positive for a micro-organism. No contamination was found in the tablets themselves.
B. Braun Medical Inc. recalled 47,148 containers of Sodium Chloride Injection on August 18, 2025. The recall follows the discovery of particulate matter in the product. Consumers and healthcare providers must stop using the injection immediately.
Boston Scientific recalled 19 units of the ICEfx Cryoablation System on August 18, 2025. The recall stems from improperly tightened end caps on certain desiccant tube subassemblies. Patients and healthcare providers should stop using the device immediately.
Aesculap AG recalled three surgical instruments on August 18, 2025, due to mislabeling issues. The ELAN 4 FIXED DURAGUARD LONG was incorrectly labeled as "Standard" and vice versa. The recall affects devices distributed in the U.S. and several international markets.
CORNEAT VISION recalled 180 units of EverPatch+ on August 18, 2025, due to a risk of conjunctival wound dehiscence. This defect may lead to early exposure of the surgical patch. The recall affects distribution across the United States and several countries.
Aesculap AG recalled one unit of the ELAN 4 FIXED DURAGUARD STANDARD on August 18, 2025. The product was mislabeled, leading to potential use confusion. The recall affects distribution in the US and multiple international locations.
CorNeat Vision recalled 630 units of the EverPatch surgical matrix on August 18, 2025. The recall follows complaints of conjunctival wound dehiscence leading to potential exposure of the surgical patch. The product was distributed worldwide, including across numerous U.S. states.
Exactech recalled 11,542 reverse shoulder humeral liners on August 15, 2025. The devices have an articular surface position outside of the specified dimensions. This recall affects units distributed worldwide, including several U.S. states.
Maquet Cardiovascular recalled the Heartstring III Proximal Seal System on August 15, 2025, due to three identified failure modes. These failures include issues with the seal's loading, deployment, and hemostasis. The recall affects 168 units distributed worldwide.
ETHICON recalled 516 units of the STRATAFIX Spiral PDS Plus device on August 15, 2025. The recall follows reports of potential barb non-engagement that could affect surgical procedures. Healthcare providers and patients must stop using the device immediately.
Maquet Cardiovascular recalled 16,512 Heartstring III Proximal Seal Systems due to critical failure modes. The recall affects devices distributed globally since August 15, 2025. Users must stop using the device immediately and follow manufacturer instructions.
Maquet Cardiovascular recalled 32,867 units of the Heartstring III Proximal Seal System on August 15, 2025. Three failure modes can lead to inadequate hemostasis during procedures. Patients and healthcare providers must stop using this device immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.